Reports Q2 revenue $76.7M, consensus $72.52M. “We delivered an excellent second-quarter performance on all fronts,” said Yossi Carmil, Cellebrite’s CEO. “Overall, our market is healthy, our customer relationships remain strong, and our investment in powerful, customer-driven innovation and go-to-market activities enabled us to continue winning. Our second-quarter 2023 revenue growth demonstrates our ongoing success in expanding the scope of our relationships within the digital forensics units of our existing customers and our progress in extending our reach into their investigative units. The combination of strong revenue growth and disciplined spending enabled us to exceed our Adjusted EBITDA and cash generation targets entering the second quarter. Our increased outlook for 2023 reflect our solid momentum in a healthy market.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CLBT:
- Cellebrite Announces Second-Quarter 2023 Results
- Cellebrite Wins Five Forensic Focus 4:cast Awards, Reinforcing Standing as Digital Intelligence Leader
- Analysts See an ‘Attractive Entry Point’ in These 3 Stocks
- Cellebrite announces new capabilities for Cellebrite Guardian
- Cellebrite Enhances Evidence & Workflow Management Tech for Digital Forensics and Investigative Units with New Capabilities